Legal

Greater percentages of orthopedic specialists and neurosurgeons accept payments compared to internists, study says.

Income, price levels, Medicaid expansion all are factors in state-level analysis.

‘Charming Kitten’ believed to be a front for Islamic Revolutionary Guard Corps, according to HHS’ cybersecurity agency.

Payments could drop by almost 8.5%, according to AMA and other health care groups.

Effort to bolster primary care is part of a larger plan to increase value-based care

U.S. attorney says doctor ‘distributed drugs with a prescription pad’ in federal case.

About 5% of all deaths in U.S. are from alcohol-related causes

Revisions to 2016 document focus on provider flexibility and unique circumstances of every prescribing decision

A complaint to a medical board is a considerable challenge posing as much risk to a physician’s career as a malpractice case.

Letter to Congressional leaders says ending payments would discourage APM participation and development of new payment models

Physician groups warn cutbacks could reduce access to care

41% of American patients with insurance avoided medical care for fear it wouldn't cover the cost of treatment, according to a new survey.

Physicians, hospitals and health groups press Congress on big issues before term ends.

Problem extends beyond costs of care and health insurance, study finds

4 areas of malpractice risk physicians must know about

Primary care physicians are overworked, and patients are going elsewhere for care. Experts say help is on its way for primary care in the United States — but so is an onslaught of new demands.

Federal investigators detail separate cases involving criminal charges and civil claims.

Know the market and be reasonable when requesting changes.

Fighting pollution and climate change are at heart of new policy paper for health care sector, government regulators.

Why a report to the NPDB can be bad news for physicians.

Agency says it will begin reviewing ads before allowing them to air

Report card on U.S. health care system has marks from slightly above average to really bad.

FDA, CDC grant approve use for adults at least six months after first two-dose series, but with no booster.

Candidates working to lower prescription drug costs could gain supporters at the ballot box.

Recent actions are important, but are ‘just a drop in the bucket’ compared to primary care challenges.